Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin

European Journal of Pharmacology

Volumn 690, Issue 1-3, 2012, Pages 22-30

  Sun, Shih Han ^a   Huang, Hsiu Chen ^b   Huang, Cheng ^c   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

BT483 cells; Curcumin; Her2; MDA MB 231 Her2 cells; Skp2

Indexed keywords

CASPASE 3; CURCUMIN; CYCLIN DEPENDENT KINASE; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UBIQUITINATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CURCUMIN; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 84864449369     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.05.036     Document Type: Article

References (34)

1. B.B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R.A. Newman, C.E. Bueso-Ramos, and J.E. Price Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin. Cancer Res. 11 2005 7490 7498
2. Agrawal, D.K., Mishra, P.K., 1991. Curcumin and its analogues: potential anticancer agents. Med. Res. Rev. 30, pp. 818-860.
3. Amaral, P., Miguel, R., Mehdad, A., Cruz, C., Monteiro Grillo, I., Camilo, M., Ravasco, P., 2010. Body fat and poor diet in breast cancer women. Nutr. Hosp. 25, pp. 456-461.
4. H.P. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med. 57 1991 1 7
5. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin and cancer: an old-age disease with an age-old solution Cancer Lett. 267 2008 133 164
6. Barros, F.F., Powe, D.G., Ellis, I.O., Green, A.R., 2010. Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments. Histopathology 56, pp. 560-572.
7. A.M. Burger, and A.K. Seth The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications Eur. J. Cancer 40 2004 2217 2229
8. C.N. Chen, C.L. Wu, and J.K. Lin Propolin C from propolis induces apoptosis through activating caspases, Bid and cytochrome c release in human melanoma cells Biochem. Pharmacol. 67 2004 53 66
9. D. Frescas, and M. Pagano Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer Nat. Rev. Cancer 8 2008 438 449
10. A. Goto, T. Niki, S. Moriyama, N. Funata, H. Moriyama, Y. Nishimura, R. Tsuchida, J.Y. Kato, and M. Fukayama Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma Pathol. Int. 54 2004 675 681
11. M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek Skp2 is oncogenic and overexpressed in human cancers Proc. Natl. Acad. Sci. USA 98 2001 5043 5048
12. D. Harari, and Y. Yarden Molecular mechanisms underlying ErbB2/HER2 action in breast cancer Oncogene 19 2000 6102 6114
13. D.D. Hershko Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer Cancer 112 2008 1415 1424
14. H.C. Huang, C.L. Lin, and J.K. Lin 1,2,3,4,6-penta-O-galloyl-beta-d- glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein J. Agric. Food Chem. 59 2011 6765 6775
15. Hung, W.C., Tseng, W.L., Shiea, J., Chang, H.C., Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett. 288, pp. 156-161.
16. W.C. Hung, W.L. Tseng, J. Shiea, and H.C. Chang Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells Cancer Lett. 288 2010 156 161
17. C. La Vecchia, C. Bosetti, F. Lucchini, P. Bertuccio, E. Negri, P. Boyle, and F. Levi Cancer mortality in Europe, 2000-2004, and an overview of trends since Ann. Oncol. 21 1975 1323 1360
18. S. Lev-Ari, A. Starr, A. Vexler, V. Karaush, V. Loew, J. Greif, E. Fenig, D. Aderka, and R. Ben-Yosef Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity Anticancer Res. 26 2006 4423 4430
19. Liang, S., Singh, M., Dharmaraj, S., Gam, L.H., The PCA and LDA analysis on the differential expression of proteins in breast cancer. Dis. Markers 29, pp. 231-242.
20. S. Menard, E. Tagliabue, M. Campiglio, and S.M. Pupa Role of HER2 gene overexpression in breast carcinoma J. Cell Physiol. 182 2000 150 162
21. K. Nakayama, H. Nagahama, Y.A. Minamishima, S. Miyake, N. Ishida, S. Hatakeyama, M. Kitagawa, S. Iemura, T. Natsume, and K.I. Nakayama Skp2-mediated degradation of p27 regulates progression into mitosis Dev. Cell 6 2004 661 672
22. J.M. Pellikainen, K.M. Ropponen, V.V. Kataja, J.K. Kellokoski, M.J. Eskelinen, and V.M. Kosma Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis Clin. Cancer Res. 10 2004 7621 7628
23. S. Pervez, M.N. Khan, and M.I. Nasir Comparative predictive value of three prognostic markers - S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast J. Ayub. Med. Coll Abbottabad. 19 2007 3 5
24. M. Reichert, D. Saur, R. Hamacher, R.M. Schmid, and G. Schneider Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells Cancer Res. 67 2007 4149 4156
25. K. Schumm, S. Rocha, J. Caamano, and N.D. Perkins Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit EMBO J. 25 2006 4820 4832
26. S. Signoretti, L. Di Marcotullio, A. Richardson, S. Ramaswamy, B. Isaac, M. Rue, F. Monti, M. Loda, and M. Pagano Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer J. Clin. Invest. 110 2002 633 641
27. M.S. Squires, E.A. Hudson, L. Howells, S. Sale, C.E. Houghton, J.L. Jones, L.H. Fox, M. Dickens, S.A. Prigent, and M.M. Manson Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells Biochem. Pharmacol. 65 2003 361 376
28. F. Traub, M. Mengel, H.J. Luck, H.H. Kreipe, and R. von Wasielewski Prognostic impact of Skp2 and p27 in human breast cancer Breast Cancer Res. Treat 99 2006 185 191
29. G. Yang, G. Ayala, A. De Marzo, W. Tian, A. Frolov, T.M. Wheeler, T.C. Thompson, and J.W. Harper Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival Clin. Cancer Res. 8 2002 3419 3426
30. H.Y. Yang, H. Yang, R. Zhao, and M.H. Lee Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity J. Cell Biochem. 98 2006 128 138
31. H.Y. Yang, B.P. Zhou, M.C. Hung, and M.H. Lee Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27 J. Biol. Chem. 275 2000 24735 24739
32. H. Yoon, and R.H. Liu Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells J. Agric. Food Chem. 55 2007 3167 3173
33. D. Yu, T. Jing, B. Liu, J. Yao, M. Tan, T.J. McDonnell, and M.C. Hung Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase Mol. Cell 2 1998 581 591
34. L. Zhang, and C. Wang F-box protein Skp2: a novel transcriptional target of E2F Oncogene 25 2006 2615 2627